Our Mission:Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.The premier biotherapeutic targeting companyOur powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics.We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need. 

Ability Biologics

Hemgenix is a biotech company focused on gene therapies for rare diseases.

Hemgenix

Skysona is a biotech company specializing in gene therapies for rare diseases.

Skysona

Zynteglo is a biotech company known for its gene therapies for rare diseases.

Zynteglo

Zolgensma is a biotech company specializing in gene therapies for rare diseases.

Zolgensma

Luxturna is a biotech company focused on gene therapies for rare diseases.

Luxturna

Kite is a gene therapy company in Maryland working on innovative solutions for diseases and cancers.

Kite

Ability Bio is a biotechnology company focused on developing advanced therapies for rare and devastating diseases. Their approach combines cutting-edge science with a commitment to improving patient outcomes.

Ability Bio

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

financial_statements

network_onboarding

company_summary

signals

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

news_processing_advanced

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	Jun 20, 2024 11:33 AM	2f61bff3
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 20, 2024 1:30 PM	5d861998
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general
news basic	general	Jun 20, 2024 11:33 AM	51414a9b
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
purchaser profile	merger_acquisitions
customer profile	customers

BIO:ABILITY

Ability Bio